Akorn, Inc.
Robbins LLP: Akorn, Inc. (AKRX) Misled Shareholders According to a Recently Filed Class Action
Robbins LLP: Akorn, Inc. (AKRX) Misled Shareholders According to a Recently Filed Class Action
Robbins LLP: Taro Pharmaceutical Industries Ltd. (TARO) Misled Shareholders According to a Recently Filed Class Action
Robbins LLP Is Investigating the Officers and Directors of Juniper Pharmaceuticals, Inc. on Behalf of Shareholders
Robbins LLP Is Investigating the Officers and Directors of New York REIT, Inc. on Behalf of Shareholders
Robbins LLP: Acquisition of Genworth Financial, Inc. (GNW) by China Oceanwide Holdings Group Co., Ltd. May Not Be in Shareholders’ Best Interests
Robbins LLP: Acquisition of JP Energy Partners LP (JPEP) by American Midstream Partners, LP (AMID) May Not Be in Unitholders’ Best Interests
Robbins LLP: Acquisition of Everyday Health, Inc. (EVDY) by j2 Global, Inc.’s (JCOM) Ziff Davis, LLC May Not Be in Shareholders’ Best Interests
Robbins LLP: Power Solutions International, Inc. (PSIX) Accused of Issuing Misleading Financial Information
Robbins LLP: Puma Biotechnology, Inc. (PBYI) Investors Survive Defendants’ Motion to Dismiss in Securities Class Action
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.